SELLAS Life Sciences Group, Inc. (SLS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 411.12M |
| Enterprise Value | 340.23M |
| P/E Ratio | -58.26 |
| PEG Ratio | -1.26 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 16.92 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -84.81 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.22 |
| Return On Equity | -0.36 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -26.86M |
| Net Income | -26.86M |
| Diluted EPS | -0.25 |
Balance Sheet
| Total Cash | 138.44M |
| Total Cash/Share | 0.73 |
| Total Debt | 737,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 18.83 |
| Book Value Per Share | 0.73 |
Price History
| 52-Week Change | 628.4 |
| 52-Week High | 15.88 |
| 52-Week Low | 1.39 |
| Moving Average 50 Days | 12.35 |
| Moving Average 200 Days | 7.63 |
Statistics
| Average Volume | 7.18M |
| Shares Outstanding | 186.03M |
| % Held by Institutions | 39.27 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | November 08, 2019 |
AD
